4//SEC Filing
ZUERBLIS KENNETH J 4
Accession 0001181431-12-007984
CIK 0000722104other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:33 AM ET
Size
5.3 KB
Accession
0001181431-12-007984
Insider Transaction Report
Form 4
ZUERBLIS KENNETH J
EVP, Chief Financial Officer
Transactions
- Award
Option to Purchase Common Stock, $.01 par value
2012-02-01$2.26/sh+100,000$226,000→ 100,000 totalExercise: $2.26From: 2013-02-01Exp: 2022-02-01→ Common Stock, $.01 par value per share (100,000 underlying)
Footnotes (1)
- [F1]These options vest as to one-third on each of the first three anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001007923
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 6:33 AM ET
- Size
- 5.3 KB